Can I read Pioglitazone and SGLT2 Inhibitors in MASLD on EtoBox?
Pioglitazone and SGLT2 Inhibitors in MASLD by huangscalbert is a document available to read on EtoBox.
What is Pioglitazone and SGLT2 Inhibitors in MASLD about?
This meta-analysis evaluates the efficacy and safety of pioglitazone versus SGLT2 inhibitors in Asian patients with metabolic dysfunction-associated steatohepatopathy (MASLD) and type 2 diabetes. The analysis of nine randomized controlled trials with 755 participants indicates that SGLT2 inhibitors are more effective than pioglitazone in improving liver fibrosis, body composition, and metabolic parameters. These findings support the use of SGLT2 inhibitors as a preferred treatment option in this patient pop
- Author
- huangscalbert
- Language
- EN